peptide elongation factor 2 has been researched along with Disease Models, Animal in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Ball, LE; Chung, D; Hurst, KE; Lawrence, KA; Robino, RA; Thaxton, JE | 1 |
| Ma, T; Ryazanov, AG; Yang, W; Zhou, X | 1 |
| Beckelman, BC; Kasica, NP; Keene, CD; Ma, T; Ryazanov, AG; Yang, W; Zhou, X; Zimmermann, HR | 1 |
| Bernstein, CN; Eissa, N; Ghia, JE; Hussein, H; Rabbi, MF; Wang, H | 1 |
| Guo, W; Li, J; Liu, X; Shi, J; Wu, X; Yan, D; Yang, C; Zhang, C; Zhao, J | 1 |
| De Gassart, A; Demaria, O; Gilliet, M; Martinon, F; Panes, R; Ryazanov, AG; Zaffalon, L | 1 |
| Bramham, CR; Dagestad, G; Grønli, J; Milde, AM; Murison, R | 1 |
| Cortés, JR; Davis, RJ; González-Rodríguez, Á; González-Terán, B; Manieri, E; Martín, P; Matesanz, N; Rodríguez, ME; Sabio, G; Valverde, Á; Valverde, ÁM; Verdugo, Á | 1 |
| Burda, J; García, L; Martín, ME; O'Loghlen, A; Salinas, M | 1 |
| Holtz, J; Jäger, D; Müller, SP; Müller-Werdan, U; Pönicke, K; Werdan, K | 1 |
11 other study(ies) available for peptide elongation factor 2 and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Remodeling Translation Primes CD8
Topics: Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Coculture Techniques; Disease Models, Animal; Female; Immunotherapy; Interleukin-15; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Neoplasms; Peptide Elongation Factor 2; Protein Biosynthesis | 2020 |
Suppression of the kinase for elongation factor 2 alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Disease Models, Animal; Hippocampus; Imidazoles; Long-Term Potentiation; Mice, Transgenic; Neuronal Plasticity; Peptide Elongation Factor 2; Phosphorylation; Protein Biosynthesis; Receptor, Metabotropic Glutamate 5 | 2021 |
Genetic reduction of eEF2 kinase alleviates pathophysiology in Alzheimer's disease model mice.
Topics: Alzheimer Disease; Animals; Dendritic Spines; Disease Models, Animal; Elongation Factor 2 Kinase; Female; Humans; Long-Term Potentiation; Male; Mice; Mice, Knockout; Peptide Elongation Factor 2; Phosphorylation; Post-Synaptic Density; Signal Transduction | 2019 |
Stability of Reference Genes for Messenger RNA Quantification by Real-Time PCR in Mouse Dextran Sodium Sulfate Experimental Colitis.
Topics: Animals; Colitis; Dextran Sulfate; Disease Models, Animal; Gene Expression; Gene Expression Profiling; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Peptide Elongation Factor 2; Real-Time Polymerase Chain Reaction; RNA Stability; RNA, Messenger; TATA-Box Binding Protein; Tumor Necrosis Factor-alpha | 2016 |
Phosphorylated eEF2 is SUMOylated and induces cardiomyocyte apoptosis during myocardial ischemia reperfusion.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Disease Models, Animal; Male; Myocardial Reperfusion; Myocytes, Cardiac; Peptide Elongation Factor 2; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley; Sumoylation | 2017 |
Pharmacological eEF2K activation promotes cell death and inhibits cancer progression.
Topics: AMP-Activated Protein Kinases; Animals; Cell Death; Cell Line; Cell Survival; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Drug Resistance; Elongation Factor 2 Kinase; Female; Gene Expression; Humans; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Knockout; Multiprotein Complexes; Nelfinavir; Neoplasms; Peptide Elongation Factor 2; Phosphorylation; Protein Biosynthesis; TOR Serine-Threonine Kinases; Tumor Burden | 2016 |
Post-transcriptional effects and interactions between chronic mild stress and acute sleep deprivation: regulation of translation factor and cytoplasmic polyadenylation element-binding protein phosphorylation.
Topics: Analysis of Variance; Animals; Body Weight; Brain; Corticosterone; Disease Models, Animal; Electroencephalography; Electromyography; Eukaryotic Initiation Factor-4E; Gene Expression Regulation; Male; Peptide Elongation Factor 2; Phosphorylation; Rats; Rats, Sprague-Dawley; RNA-Binding Proteins; RNA, Messenger; Sleep Deprivation; Stress, Psychological; Transcription Factors | 2012 |
Eukaryotic elongation factor 2 controls TNF-α translation in LPS-induced hepatitis.
Topics: Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Gene Expression Regulation; HEK293 Cells; Humans; Lipopolysaccharides; Macrophages; MAP Kinase Kinase 3; MAP Kinase Kinase 6; MAP Kinase Signaling System; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 12; Mitogen-Activated Protein Kinase 13; Peptide Chain Elongation, Translational; Peptide Elongation Factor 2; Tumor Necrosis Factor-alpha | 2013 |
Does phosphorylation of eukaryotic elongation factor eEF2 regulate protein synthesis in ischemic preconditioning?
Topics: Animals; Brain; Brain Ischemia; Cerebral Cortex; Disease Models, Animal; Down-Regulation; Hippocampus; Hydrogen Peroxide; Ischemic Preconditioning; Nerve Tissue Proteins; Oxidative Stress; Peptide Elongation Factor 2; Phosphorylation; Rats; Rats, Wistar; Reaction Time; Reperfusion Injury | 2004 |
The impact of insulin-like growth factor-1 on the pattern of cardiac elongation factor-2 variants in a model of overload.
Topics: Animals; Apoptosis; Body Weight; Cardiomegaly; Disease Models, Animal; DNA Fragmentation; Enzyme Inhibitors; Genetic Variation; Heart; Hemodynamics; Hypertension; Insulin-Like Growth Factor I; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptide Elongation Factor 2; Rats; Rats, Wistar | 2002 |